RIOPAN

This brand name is authorized in Austria, Brazil, Germany, Italy

Active ingredients

The drug RIOPAN contains one active pharmaceutical ingredient (API):

1 Magaldrate
UNII 0MFM55849I - MAGALDRATE ANHYDROUS

Magaldrate is a common antacid drug that is used for the treatment of duodenal and gastric ulcers, esophagitis from gastroesophageal reflux.

Read about Magaldrate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A02AD02 Magaldrate A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02A Antacids → A02AD Combinations and complexes of aluminium, calcium and magnesium compounds
Discover more medicines within A02AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 501103004130418
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 00749293, 00749301, 00749318, 01139645, 01139668, 07110186, 08592922, 08592939, 08592945
Country: IT Agenzia del Farmaco Identifier(s): 027103023, 027103035, 027103047

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.